We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$15B
Cap. Flow %
-2.25%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.82%
2 Technology 1.6%
3 Consumer Discretionary 1.3%
4 Financials 0.99%
5 Communication Services 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEWP
11776
New Pacific Metals
NEWP
$1.3B
$144K ﹤0.01%
49,066
+37,766
+334% +$123K
NGNE icon
11777
Neurogene
NGNE
$732M
$144K ﹤0.01%
1,493
+126
+9% +$15.3K
TIMB icon
11778
TIM SA
TIMB
$8.38B
$144K ﹤0.01%
+12,385
New +$140K
VOR icon
11779
Vor Biopharma
VOR
$1.34B
$144K ﹤0.01%
+618
New +$178K
YSG
11780
CALL
Yatsen Holding
YSG
$285M
$144K ﹤0.01%
13,360
-10,120
-43% -$142K
SPPI
11781
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$144K ﹤0.01%
113,200
-28,800
-20% -$51.5K
STRE.U
11782
DELISTED
Supernova Partners Acquisition Company III, Ltd. Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant
STRE.U
$144K ﹤0.01%
14,588
BLRX
11783
BioLineRX
BLRX
$11.4M
$143K ﹤0.01%
1,756
-186
-10% -$19.4K
RNW icon
11784
CALL
ReNew
RNW
$2.49B
$143K ﹤0.01%
18,400
-158,400
-90% -$1.39M
YCBD icon
11785
CALL
cbdMD
YCBD
$5.6M
$143K ﹤0.01%
369
-48
-12% -$27.9K
ITI
11786
DELISTED
Iteris, Inc.
ITI
$143K ﹤0.01%
35,720
-41,003
-53% -$198K
FRSGU
11787
DELISTED
First Reserve Sustainable Growth Corp. Unit
FRSGU
$143K ﹤0.01%
+14,177
New +$145K
EXTN
11788
PUT
DELISTED
Exterran Corporation
EXTN
$143K ﹤0.01%
48,000
+1,900
+4% +$7.53K
ETTX
11789
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$143K ﹤0.01%
+65,346
New +$177K
ACTG icon
11790
CALL
Acacia Research
ACTG
$436M
$142K ﹤0.01%
27,700
-65,400
-70% -$353K
CLPT icon
11791
PUT
ClearPoint Neuro
CLPT
$474M
$142K ﹤0.01%
12,700
-34,300
-73% -$513K
EC icon
11792
PUT
Ecopetrol
EC
$33.9B
$142K ﹤0.01%
+11,000
New +$157K
PPIH
11793
Perma-Pipe International
PPIH
$216M
$142K ﹤0.01%
+16,491
New +$138K
PPTA
11794
Perpetua Resources
PPTA
$3.14B
$142K ﹤0.01%
+29,833
New +$145K
DGXX
11795
Digi Power X Inc
DGXX
$378M
$142K ﹤0.01%
+30,640
New +$151K
ENZ
11796
CALL
DELISTED
Enzo Biochem, Inc.
ENZ
$142K ﹤0.01%
44,100
+13,100
+42% +$44.7K
TCON
11797
CALL
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$142K ﹤0.01%
2,570
+175
+7% +$11.2K
SIOX
11798
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$142K ﹤0.01%
109,825
+82,264
+298% +$146K
LOPX
11799
DELISTED
Direxion Low Priced Stock ETF
LOPX
$142K ﹤0.01%
+18,726
New +$165K
EARN
11800
Ellington Residential Mortgage REIT
EARN
$167M
$141K ﹤0.01%
+13,617
New +$156K

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.